Cargando…
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495723/ https://www.ncbi.nlm.nih.gov/pubmed/36139711 http://dx.doi.org/10.3390/antiox11091637 |
_version_ | 1784794089278930944 |
---|---|
author | Poljšak, Borut Kovač, Vito Milisav, Irina |
author_facet | Poljšak, Borut Kovač, Vito Milisav, Irina |
author_sort | Poljšak, Borut |
collection | PubMed |
description | Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the interest in the use of NAD+ boosters as dietary supplements, both in scientific circles and among the general population. Here, we discuss the current trends in NAD+ precursor usage as well as the uncertainties in dosage, timing, safety, and side effects. There are many unknowns regarding pharmacokinetics and pharmacodynamics, particularly bioavailability, metabolism, and tissue specificity of NAD+ boosters. Given the lack of long-term safety studies, there is a need for more clinical trials to determine the proper dose of NAD+ boosters and treatment duration for aging prevention and as disease therapy. Further research will also need to address the long-term consequences of increased NAD+ and the best approaches and combinations to increase NAD+ levels. The answers to the above questions will contribute to the more efficient and safer use of NAD+ boosters. |
format | Online Article Text |
id | pubmed-9495723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94957232022-09-23 Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies Poljšak, Borut Kovač, Vito Milisav, Irina Antioxidants (Basel) Review Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the interest in the use of NAD+ boosters as dietary supplements, both in scientific circles and among the general population. Here, we discuss the current trends in NAD+ precursor usage as well as the uncertainties in dosage, timing, safety, and side effects. There are many unknowns regarding pharmacokinetics and pharmacodynamics, particularly bioavailability, metabolism, and tissue specificity of NAD+ boosters. Given the lack of long-term safety studies, there is a need for more clinical trials to determine the proper dose of NAD+ boosters and treatment duration for aging prevention and as disease therapy. Further research will also need to address the long-term consequences of increased NAD+ and the best approaches and combinations to increase NAD+ levels. The answers to the above questions will contribute to the more efficient and safer use of NAD+ boosters. MDPI 2022-08-24 /pmc/articles/PMC9495723/ /pubmed/36139711 http://dx.doi.org/10.3390/antiox11091637 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Poljšak, Borut Kovač, Vito Milisav, Irina Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title | Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title_full | Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title_fullStr | Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title_full_unstemmed | Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title_short | Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies |
title_sort | current uncertainties and future challenges regarding nad+ boosting strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495723/ https://www.ncbi.nlm.nih.gov/pubmed/36139711 http://dx.doi.org/10.3390/antiox11091637 |
work_keys_str_mv | AT poljsakborut currentuncertaintiesandfuturechallengesregardingnadboostingstrategies AT kovacvito currentuncertaintiesandfuturechallengesregardingnadboostingstrategies AT milisavirina currentuncertaintiesandfuturechallengesregardingnadboostingstrategies |